Spinraza Delays Found Not to Directly Affect Children in Italy

Spinraza Delays Found Not to Directly Affect Children in Italy

312584

Spinraza Delays Found Not to Directly Affect Children in Italy

Delayed Spinraza (nusinersen) treatment due to the COVID-19 pandemic did not directly result in a worsening of symptoms in children with spinal muscular atrophy (SMA), a small study suggests. Any worse motor function that occurred during this period was attributed to a lack of response to the therapy or difficulties in family situations, the researchers wrote. The study, “Effect of the COVID-19 Pandemic on Children With SMA Receiving Nusinersen: What Is Missed and What Is…

You must be logged in to read/download the full post.